CClinicalTrials.gg
Status unknownNCT03730389Updated Nov 5, 2018

External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone

An interventional study of External Physical Vibration Lithecbole (EPVL) in Ureteral Calculi, sponsored by Guohua Zeng. Status unknown at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-11-05.

Sponsored by Guohua Zeng · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Aug 2018, registered Nov 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The investigator aims to perform a prospective and randomized controlled trial evaluating the safety and efficacy of External Physical Vibration Lithecbole(EPVL) in treating 4-10 mm ureteral stone.

Read the detailed description

Patients with ureteral stones less than 10 mm, would receive observation for stone passage, not requiring immediate surgery. There are many studies evaluating the effect of Medical expulsive therapy in treating ureteral stones, including a-blockers, and calcium channel blockers. Most of shuties concluded that the benefit of a-blockers might be among those with larger (distal) stones. There is no good method for the removal of upper ureteral calculi, except drinking water and exercising.

Recently, a new extracorporeal physical vibrational lithecbole (EPVL) device named Friend-I EPVL (Zhengzhou Fu Jian Da Medical Instrument Co., Zhengzhou, China) has proven to be an effective treatment for upper urinary tract residual calculi. The device was approved by the Chinese food and drug administration in 2012. A Simple harmonic motion technology in multi-direction was applied. The Lateral acceleration was provided by the physical vibration device in the base through the harmonic vibration wave in the horizontal direction, which induces the urinary stone separate with the kidney or ureter, and expands a moving space for the stone. Meanwhile, an axial effect was produced to push the stone by the physical vibration device in the handle through the harmonic vibration wave in the multi- direction. So, we think that EPVL may be effective in treating ureteral stones.

02

Conditions studied

  • Ureteral Calculi

Keywords

  • Ureteral Calculi
  • External Physical Vibration Lithecbole (EPVL)
  • Efficacy
  • Safety
03

In context

Ureteral Calculi

120 studies on the registry are indexed under Ureteral Calculi; 23 are open to participants now.

This study's planned enrollment of 208 is above the median of 100 across 97 interventional studies indexed under Ureteral Calculi.

Browse Ureteral Calculi studies →

Lead sponsor

Guohua Zeng is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adults age 18 to 70 years
  2. 4-10 mm single ureteral calculi
  3. Normal serum creatinine
  4. ASA grading: 1-2 levels.

Exclusion criteria

Exclusion Criteria:

  1. Pregnant or isolated kidney patients
  2. Moderate or severe hydronephrosis
  3. History of ureteral stricture
  4. Multiple ureteral stones;
  5. Acute urinary tract infection
  6. Those who are taking α-receptor, calcium channel blocker or chinese medicine stone shovel
  7. Dysfunction of blood coagulation
  8. Obese patients (body mass index > 28 kg / m2);
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
208 participants (estimated)

Study arms

  • Experimental
    EPVL Group

    In treatment group, patients were given one to three sessions of External Physical Vibration Lithecbole therapy in two weeks. These patients were also instructed to drink a minimum of 2500 ml water daily and take more exercise.

    Device: External Physical Vibration Lithecbole (EPVL)

  • No intervention
    Traditional Group

    patients with 4-10mm ureteral stone, were treated by traditional treatment methods, including drinking a minimum of 2500 ml water daily and taking more exercise.

Interventions

  • DeviceExternal Physical Vibration Lithecbole (EPVL)

    Using the the way of external physical vibration to promote separation of stones from ureteral mucosa and promoting the excretion of ureteral stones

06

What researchers measure

Primary outcomes

  1. Number of Participants With Stone Expulsion

    The stone discharge rate of the two group

    Time frame: 14 days

Secondary outcomes

  1. Time to Stone Passage

    Time to stone elimination in days in patients with spontaneous elimination

    Time frame: 14 days

  2. The rate of renal colic

    the mean rate of renal colic between the two groups

    Time frame: 14 days

  3. Required Analgesics

    the need for slow-released diclofenac tablet

    Time frame: 14 days

07

Study locations

1 of 1 sites recruiting
  • Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong 510230, China
    • Guohua Zeng, Ph.D & MD. · Contact · gzgyzgh@vip.sina.com · +86 13802916676
    • Guohua Zeng, Ph.D & MD. · Principal investigator
    • Chao Cai, PH.D & MD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03730389
Lead sponsor
Guohua Zeng
Responsible party
Guohua Zeng (Vice president, The First Affiliated Hospital of Guangzhou Medical University) — Sponsor-investigator
First posted
Nov 5, 2018
Start date
Aug 1, 2018
Primary completion
Aug 1, 2020 (estimated)
Completion
Nov 1, 2020 (estimated)
Last update
Nov 5, 2018

Study contacts

Guohua Zeng, Ph.D and M.D.
Contact
gzgyzgh@vip.tom.cn
+86 13802916676
Guohua Zeng, PH.D & MD
principal investigator · The First Affiliated Hospital of Guangzhou Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion